BioRad Laboratories (BIO)
(Delayed Data from NYSE)
$314.94 USD
+4.91 (1.58%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $315.00 +0.06 (0.02%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth C Momentum D VGM
Company Summary
Hercules, CA-headquartered Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components.
Bio-Rad has extensive and direct distribution channels in over 35 countries outside the United States through subsidiaries which focus on sales, customer service and product distribution.
The company operates through two ...
Company Summary
Hercules, CA-headquartered Bio-Rad Laboratories is a manufacturer and global supplier of clinical diagnostics and life science research products in the healthcare, analytical chemistry life science research and other markets. It offers a wide portfolio of products and systems which allow the separation of complex chemical and biological materials and discovery, analysis and purification of their components.
Bio-Rad has extensive and direct distribution channels in over 35 countries outside the United States through subsidiaries which focus on sales, customer service and product distribution.
The company operates through two reportable segments. Together, these segments offer over 12,000 different products and services. The details are as follows:
Life Science (44.2% of total revenues in 2023; down 4.9% at CER from 2022): This segment designs, manufactures, markets and services reagents, apparatus and instruments utilized for biological research. Principal life science customers include universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, food producers and food testing laboratories. The company believes Life Science Segment represents a global market opportunity of approximately $9 billion annually.
Clinical Diagnostics (55.8%; up 3.2%): This business markets and distributes products to reference laboratories, hospital laboratories, state newborn screening facilities, physicians’ office laboratories, transfusion laboratories as well as insurance and forensic testing laboratories. It designs, manufactures, distributes and services automated test systems, informatics systems, test kits and specialized quality controls for the healthcare market. According to Bio-Rad, the Clinical Diagnostics segment presents an annual global market opportunity of roughly $12 billion.
General Information
BioRad Laboratories, Inc
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
Phone: 510-724-7000
Fax: 510-741-5817
Email: ir@bio-rad.com
Industry | Medical - Products |
Sector | Medical |
Fiscal Year End | December |
Last Reported Quarter | 6/30/2024 |
Exp Earnings Date | 10/24/2024 |
EPS Information
Current Quarter EPS Consensus Estimate | 2.42 |
Current Year EPS Consensus Estimate | 10.32 |
Estimated Long-Term EPS Growth Rate | NA |
Exp Earnings Date | 10/24/2024 |
Price and Volume Information
Zacks Rank | ![]() |
Yesterday's Close | 310.03 |
52 Week High | 406.44 |
52 Week Low | 261.59 |
Beta | 0.93 |
20 Day Moving Average | 232,868.30 |
Target Price Consensus | 366.50 |
4 Week | -1.40 |
12 Week | 9.79 |
YTD | -2.46 |
4 Week | -4.47 |
12 Week | 2.83 |
YTD | -17.79 |
Shares Outstanding (millions) | 27.87 |
Market Capitalization (millions) | 8,777.58 |
Short Ratio | NA |
Last Split Date | 3/8/2002 |
Dividend Yield | 0.00% |
Annual Dividend | $0.00 |
Payout Ratio | 0.00 |
Change in Payout Ratio | 0.00 |
Last Dividend Payout / Amount | NA / $0.00 |
Fundamental Ratios
P/E (F1) | 30.52 |
Trailing 12 Months | 29.08 |
PEG Ratio | NA |
vs. Previous Year | 3.67% |
vs. Previous Quarter | 35.81% |
vs. Previous Year | -6.26% |
vs. Previous Quarter | 4.53% |
Price/Book | 1.29 |
Price/Cash Flow | 26.02 |
Price / Sales | 3.43 |
6/30/24 | 3.77 |
3/31/24 | 3.59 |
12/31/23 | 3.90 |
6/30/24 | 2.68 |
3/31/24 | 2.55 |
12/31/23 | 2.77 |
6/30/24 | 6.28 |
3/31/24 | 6.57 |
12/31/23 | 5.83 |
6/30/24 | 4.63 |
3/31/24 | 4.89 |
12/31/23 | 4.34 |
6/30/24 | 12.14 |
3/31/24 | 11.94 |
12/31/23 | 12.92 |
6/30/24 | -51.73 |
3/31/24 | -12.37 |
12/31/23 | -23.86 |
6/30/24 | -67.50 |
3/31/24 | -17.04 |
12/31/23 | -31.82 |
6/30/24 | 243.22 |
3/31/24 | 317.32 |
12/31/23 | 306.51 |
6/30/24 | 1.50 |
3/31/24 | 1.56 |
12/31/23 | 1.61 |
6/30/24 | 0.18 |
3/31/24 | 0.13 |
12/31/23 | 0.14 |
6/30/24 | 15.04 |
3/31/24 | 11.70 |
12/31/23 | 12.06 |